Cargando…
Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine
Oncolytic virotherapy is emerging as an important agent in cancer treatment. In a previous study, we designed and constructed Ad-Apoptin-hTERTp-E1a (Ad-VT), a dual cancer-selective anti-tumor recombinant adenovirus. In this study, crystal violet staining and WST-1 assays showed that Ad-VT has a sign...
Autores principales: | Liu, Xing, Yang, Zhiguang, Li, Yiquan, Zhu, Yilong, Li, Wenjie, Li, Shanzhi, Wang, Jing, Cui, Yingli, Shang, Chao, Liu, Zirui, Song, Gaojie, Li, Ce, Li, Xiao, Shao, Guoguang, Jin, Ningyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052302/ https://www.ncbi.nlm.nih.gov/pubmed/32158698 http://dx.doi.org/10.3389/fonc.2020.00229 |
Ejemplares similares
-
Anti‐tumour effects of a dual cancer‐specific oncolytic adenovirus on Breast Cancer Stem cells
por: Li, Wenjie, et al.
Publicado: (2020) -
A comparative study of the ability of recombinant oncolytic adenovirus, doxorubicin and tamoxifen to inhibit the proliferation of breast cancer cells
por: Li, Shanzhi, et al.
Publicado: (2022) -
Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapy
por: Binz, Eike, et al.
Publicado: (2015) -
Synergistic antitumor effect of the combination of a dual cancer-specific oncolytic adenovirus and cisplatin on lung cancer cells
por: Jin, Jing, et al.
Publicado: (2018) -
Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo
por: Wang, Jing, et al.
Publicado: (2022)